Thalomid

Report
20 Pages
August 2018
Region: Global
Citeline
ID: 4775171

Drug Overview
Thalomid (Celgene) contains thalidomide, a glutamic acid derivative that possesses immunomodulatory, anti-inflammatory, and anti-angiogenic properties.

The drug’s mechanism of action is not fully understood, but it is presumed to inhibit both the production of tumor necrosis factor-alpha in stimulated peripheral monocytes, and the activities of interleukins and interferons.

It also exhibits pro-angiogenic effects and is found to inhibit both the vascular endothelial growth factor and basic fibroblast growth factor.

OVERVIEW

Drug Overview
Product Profiles
Thalomid : Multiple myeloma

LIST OF FIGURES

Figure 1: Thalomid for multiple myeloma – SWOT analysis
Figure 2: The authors drug assessment summary of Thalomid for multiple myeloma
Figure 3: The authors drug assessment summary of Thalomid for multiple myeloma
Figure 4: Thalomid sales for multiple myeloma across the US, Japan, and five major EU markets, by country, 2017–26

LIST OF TABLES

Table 1: Thalomid drug profile
Table 2: Thalomid pivotal trial data in multiple myeloma
Table 3: Thalomid late-phase trial data in multiple myeloma
Table 4: Thalomid sales for multiple myeloma across the US, Japan, and five major EU markets, by country ($m), 2017–26
Table 5: Patients treated with Thalomid across the US, Japan, and five major EU markets, by country, 2017–26

Table of Contents

Related Topics

Related Reports

Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Global Multiple Myeloma Drugs Market 2023-2027

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)